Antiplatelets Pharmaco Flashcards

1
Q

What is Pharmacogenetics

A

Study of genetic cause of individual variations with drug response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is pharmacogenomic

A

Genome wide analysis of genetic determinant of drug efficacy and toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Two forms of variability

A

PK variability

PD variability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Differences in those concepts leads to PK variability

A

Absorption
distribution
metabolism
elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If variation is due to genes what could be possible causes

A

Single nucleotide polymorphism

insertion /deletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Frequency of single nucleotide polymorphism in human genome

A

Every hundred to 1000 base pairs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Population with highest number of the population specific polymorphism

A

African Americans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does pharmacokinetic variability refers to

A

Variability in the amount of drug delivered to a receptor depending on factors such as Absorption Distribution metabolism and excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does Pharmacogenetics Like to focus on in drug pharmacokinetics factors

A

Metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the goal of metabolism

A

Conversion of foreign substances or or xenobiotics into water soluble metabolites which are more easily excreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Enzymes involved in metabolism

A

Xenobiotics metabolizing enzymes

drug metabolizing enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Example of prodrug

A

Codeine into morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a poor metabolizer phenotype

A

Enzyme deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Can poor metabolizer phenotype lead to toxic drug concentration

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Can poor metabolizer phenotype need to save therapeutic effect of prodrug

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is an ultra rapid metabolizer phenotype

A

Has increased in gene copy number with increased expression of active enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Do ultra rapid metabolizers have ineffective drug therapy due to low drug concentration at target sides

18
Q

Do ultra Rapid metabolizer have high therapeutic efficacy when it comes to prodrug

19
Q

Can you have polymorphism of drug transporters in absorption distribution and excretion

20
Q

Two categories of drug metabolizing enzyme

A

Phase 1 functionalizinf enzyme

Phase 2 conjugating enzyme

21
Q

What do phase I enzymes do

A

Introduce or remove functional group in drug through oxidation , reduction or hydrolysis

22
Q

What do phase II enzymes do

A

Transfer moieties from cofactor to a substrate

23
Q

Main phase I enzymes

24
Q

4 phenotypes of patients based on CYP

A

Poor metabolizer - abolished activity
Intermediate metabolizer - reduced activity
Extensive metabolizer - normal activity
Ultra rapid metabolizer - enhanced activity

25
Should you increase or reduce dose of drugs in PM patient metabolized by phase I enzymes
Lower
26
Should you increase or reduce dose of drugs in UM patient metabolized by phase I enzymes
Increase
27
Main enzymes with high polymorphism
CYP2D6 CYP2C9 CYP2C19 Plasma cholinesterase
28
Amtiplagels wirh high variability
Clopidogrel Warfarin Dabigatran
29
Is clopidogrel a prodrug
Yes
30
What is the action of clopidogrel
Irreversibly binds to platelet ADP receptor leading to platelet aggregation inhibition
31
Metabolism of clopidogrel
CYP450 | CYP2C19
32
Enzymes involved in clopidogrel metabolism
CYP2C19
33
Loss of function CYP2C19 2 and 3consequence
Adverse ischemic event
34
CYP2C19 17 gain of function consequence
Higher catalytic effect Decreased ischemic event Risk of bleeding
35
Action of warfarin
Vitamin K antagonist used in prevention of Venus thromboembolism
36
Enzyme involved in metabolism of warfarin
CYP2c9 enzyme
37
What is the function of CYP2C9 2 anD 3 leads to…
Increased risk of bleeding by impairing warfarin metabolism
38
Gene responsible for polymorphism of
VKORC1
39
If a person has expression of VKORC1 variant , Are they more sensitive or insensitive to warfarin
Sensitiv
40
What is the dabigatran Etexilate
Prodrug which metabolizes esterases into direct thrombin inhibitor dabigatran
41
What is the polymorphism of dabigatran
Single nucleotide polymorphism in CES1 gene Which decreases concentration of dabigatran